| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.568 | 14.422 | 16.214 | 23.105 | 9.869 | 9.514 | 14.274 | 10.181 | 16.446 | 8.980 |
| Total Income - EUR | 88.637 | 62.186 | 39.692 | 23.105 | 9.925 | 9.514 | 14.274 | 10.181 | 18.472 | 12.090 |
| Total Expenses - EUR | 74.937 | 55.182 | 55.203 | 51.062 | 45.794 | 41.637 | 40.901 | 36.493 | 34.838 | 26.274 |
| Gross Profit/Loss - EUR | 13.699 | 7.004 | -15.511 | -27.958 | -35.869 | -32.123 | -26.627 | -26.312 | -16.366 | -14.184 |
| Net Profit/Loss - EUR | 13.292 | 6.860 | -16.335 | -28.189 | -35.968 | -32.215 | -26.644 | -26.414 | -16.550 | -14.184 |
| Employees | 4 | 4 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Adomedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 220.310 | 192.046 | 163.975 | 138.085 | 113.718 | 89.591 | 66.806 | 51.796 | 40.376 | 28.721 |
| Current Assets | 1.725 | 1.183 | 564 | 2.827 | 727 | 964 | 342 | 675 | 2.481 | 113 |
| Inventories | 65 | 63 | 61 | 74 | 73 | 72 | 70 | 70 | 70 | 0 |
| Receivables | 1.439 | 985 | 273 | 113 | 433 | 0 | 74 | 157 | 77 | 52 |
| Cash | 221 | 136 | 231 | 2.640 | 221 | 892 | 198 | 449 | 2.334 | 61 |
| Shareholders Funds | 28.142 | 34.715 | 17.792 | -10.723 | -46.484 | -77.818 | -102.736 | -129.469 | -145.626 | -159.176 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 121.508 | 158.514 | 146.747 | 151.636 | 160.929 | 168.372 | 169.884 | 181.939 | 188.483 | 188.010 |
| Income in Advance | 72.384 | 23.882 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6311 - 6311" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Adomedica S.r.l.